Remdesivir potently inhibits carboxylesterase‐2 through covalent modifications: signifying strong drug‐drug interactions is a research paper published in Fundamental and Clinical Pharmacology (2020). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIBIB NIH HHS
Grant: R01 EB018748
NIAID NIH HHS
Grant: R21 AI153031
FWCI
1.77
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals